The world’s leading ophthalmic optics company, Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its mission is to improve lives by improving sight. To support this mission, Essilor allocates more than €200 million to research and innovation every year, in a commitment to continuously bring new, more effective products to market.
Its flagship brands are Varilux®, Crizal®, Transitions®, Eyezen™, Xperio®, Foster Grant®, and Bolon™. Essilor also develops and markets equipment, instruments and services for eyecare professionals.
With close to 74,000 employees worldwide, Essilor operates a global network of 33 plants, 449 prescription laboratories and edging facilities, 14 distribution centers, as well as 5 research and development centers around the world.
The International Myopia Institute (IMI) represents the consensus body of global myopia experts working towards the ultimate goal of advancing myopia research and education, to prevent blindness in the future. Olga Prenat, Global Director of Education and Professional Relations at Essilor International and Chief Editor of Points de Vue, recently invited myopia experts, IMI chair Prof. Serge Resnikoff, and committee members Prof. Ian Flitcroft, Prof. Earl Smith and Dr. Monica Jong to share their inspiring journey with the initiative and discuss how the white papers are critical to improving clinical myopia management.